Federal Court of Australia
FEDERAL COURT OF AUSTRALIA
Warner-Lambert Company LLC v Apotex Pty Limited (No 2) [2018] FCAFC 26 Appeal from: Apotex Pty Ltd v Warner-Lambert Company LLC (No 2) [2016] FCA 1238
File number: NSD 239 of 2017
Judges: JAGOT, YATES AND BURLEY JJ
Date of judgment: 23 February 2018
Catchwords: PATENTS – validity – sufficiency of description – consideration of proper test – whether test of "undue burden" should be applied PATENTS – validity – false suggestion – whether false suggestion made – whether false suggestion materially contributed to the grant of the patent PATENTS – infringement – Swiss claims – whether the importation of a medicament made outside the patent area by a method claimed in the patent is an infringement of the patent PATENTS – infringement – whether leave should be granted to withdraw admissions
Legislation: Patents Act 1990 (Cth) ss 13, 40, 72, 138, Sch 1 Intellectual Property Laws Amendment (Raising the Bar) Act 2012 (Cth) Patents Act 1977 (UK) ss 14, 72 Patent and Designs Act, 1907 (UK) s 2 (repealed) Convention on the Grant of European Patents (European Patent Convention) 1973, art 83
Cases cited: Alphapharm Pty Ltd v H Lundbeck A/S [2008] FCA 559; (2008) 76 IPR 618 Apotex Pty Ltd v Warner-Lambert Company LLC (No 2) [2016] FCA 1238 Coulton v Holcombe [1986] HCA 33; (1986) 162 CLR 1 Eli Lilly and Company v Pfizer Overseas Pharmaceuticals [2005] FCA 67; (2005) 64 IPR 506 Gilead Sciences Pty Ltd v Idenix Pharmaceuticals LLC [2016] FCA 169; (2016) 117 IPR 252 Kimberly-Clark Australia Pty Ltd v Arico Trading International Pty Limited [2001] HCA 8; (2001) 207 CLR 1 H Lundbeck A/S v Alphapharm Pty Ltd [2009] FCAFC 70; (2009) 177 FCR 151 Lockwood Security Products Pty Limited v Doric Products Pty Limited [2004] HCA 58; (2004) 217 CLR 274 Mentor Corporation v Hollister Inc [1991] FSR 557 Merck & Co Inc v Arrow Pharmaceuticals Ltd [2006] FCAFC 91; (2006) 154 FCR 31 New South Wales Land and Housing Corporation v Reilly [2012] NSWCA 286 No-Fume Ltd v Frank Pitchford & Co Ltd (1935) 52 RPC 231 Novartis AG v Johnson & Johnson Medical Ltd [2010] EWCA Civ 1039 Otsuka Pharmaceutical Co Ltd v Generic Health Pty Ltd (No 4) [2015] FCA 634; (2015) 113 IPR191 Otto v Linford (1882) 46 LT 35 Pfizer Overseas Pharmaceuticals v Eli Lilly & Co [2005] FCAFC 224; (2005) 225 ALR 416 R v Arkwright (1785) 1 WPC 64 Robinson Helicopter Co Inc v McDermott [2016] HCA 22; (2016) 90 ALJR 679 Saccharin Corporation Ltd v Anglo-Continental Chemical Works Ltd (1900) 17 RPC 307 Samuel Taylor Pty Ltd v SA Brush Co Ltd [1950] HCA 44; (1950) 83 CLR 617 T1743/06, Ineos/Amorphous silica (unreported) T226/85, UNILVER/Stable bleaches [1989] EPOR 18 T435/91, UNILVER/Detergents [1995] EPOR 314 T694/92, Mycogen/Modifying plant cells [1998] EPOR 114 Tramanco Pty Ltd v BPW Transpec Pty Ltd [2014] FCAFC 23; (2014) 105 IPR 18 Valensi v British Radio Corporation [1973] 90 RPC 337 Warner-Lambert Co LLC v Apotex Pty Limited [2017] FCAFC 58; (2017) 249 FCR 17 Blanco White, Patents for Inventions, 5th ed (1983), §4-502
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate